 Evofem Biosciences Inc NASDAQ: EVFM has priced its previously announced underwritten public offering of 50 million shares and accompanying short-term warrants to purchase up to an aggregate of 50 million shares. The offer price of 1.00 per share represents a discount of 22 from the last close price of 1.28 on Monday. 